April 08, 2024 01:24 PM Eastern Daylight Time
BUSINESS WIRE
Delta-Fly Pharma Inc : avis d'autorisation pour mener l'étude de Phase I/II du DFP-10917 associé au vénétoclax
Tweet
View Full Size
Download
Full Size
JPEG
,
3000
x
510
,
208.0 KB
Small
JPEG
,
480
x
82
,
30.5 KB
Preview
JPEG
,
144
x
24
,
6.6 KB
Thumbnail
JPEG
,
120
x
20
,
4.8 KB
Smart Multimedia Gallery
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Delta-Fly Pharma Inc : avis d'autorisation pour...